Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JZ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,407
Award facts
- Contract value 100% obligated
- $35,407.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,407.04 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on January 6, 2026. The award is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist indicated for chronic weight management, reflecting the federal government's investment in pharmaceutical solutions for healthcare needs within the military and defense sectors.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide. The parent company, Cencora, Inc., holds an even larger IDC with the DLA valued at up to $999,999,999.00 through December 31, 2031, positioning the organization as a critical pharmaceutical distributor for federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26F9JZ2?
SPE2DR26F9JZ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JZ2 worth?
The government has obligated $35,407 on SPE2DR26F9JZ2.
Is contract SPE2DR26F9JZ2 an order under another contract?
Yes. SPE2DR26F9JZ2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JZ2 competed?
The extent of competition for SPE2DR26F9JZ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award